IDiyas

For the Inventor, By the Inventor

Loughborough, United Kingdom

Richard Evans

USPTO Granted Patents = 8


 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Loughborough, GB (2005 - 2011)
  • Macclesfield, GB (2012)
  • Leicestershire, GB (2012 - 2014)

Company Filing History:

goldMedal8 out of 1,500 
 
Astrazeneca Ab
 patents

Years Active: 2005-2014

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 8889692 - Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses (2014-11-18),
2. 8299246 - N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses (2012-10-30),
3. 8163905 - Compounds and their uses 708 (2012-04-24),
4. 8017602 - N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (2011-09-13),
5. 7408065 - [object Object] (2008-08-05),
6. 7307090 - Piperidine derivatives useful as modulators of chemokine receptor activity (2007-12-11),
7. 7265227 - Piperidine derivatives useful as modulators of chemokine receptor activity (2007-09-04),
8. 6903085 - Substituted piperidine compounds useful as modulators of chemokine receptor activity (2005-06-07),

Title: Richard Evans: Innovator in Pharmaceutical Chemistry

Introduction

Richard Evans is a prominent inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are pyrazinone derivatives and their pharmaceutically acceptable salts. These inventions relate to specific chemical formulas and processes for their preparation. The pharmaceutical compositions containing these derivatives are designed for use in therapy, showcasing Richard's commitment to advancing medical science.

Career Highlights

Richard Evans has built a successful career at AstraZeneca AB, a leading global biopharmaceutical company. His expertise in developing novel pharmaceutical compounds has positioned him as a key player in the industry. His contributions have not only enhanced the company's portfolio but also the broader field of medicine.

Collaborations

Richard has collaborated with notable colleagues such as Piotr Antoni Raubo and Brian Springthorpe. These partnerships have fostered innovation and have been instrumental in the development of his patented inventions.

Conclusion

Richard Evans exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborations. His work continues to impact the field positively, paving the way for future advancements in therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…